1-4 of 4
Jane A. Estell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy

Clinical Trials & Observations
Emmanuel Bachy, Matthew J. Maurer, Thomas M. Habermann, Bénédicte Gelas-Dore, Delphine Maucort-Boulch, Jane A. Estell, Eric Van den Neste, Réda Bouabdallah, Emmanuel Gyan, Andrew L. Feldman, Joan Bargay, Alain Delmer, Susan L. Slager, Maria Gomes da Silva, Olivier Fitoussi, David Belada, Hervé Maisonneuve, Tanin Intragumtornchai, Stephen M. Ansell, Thierry Lamy, Peggy Dartigues, Brian K. Link, John F. Seymour, James R. Cerhan, Gilles Salles
Journal: Blood
Blood (2018) 132 (1): 49–58.
https://doi.org/10.1182/blood-2017-11-816405
Published: 2018
Includes: Supplemental data
Journal Articles

Updated 6 Year Follow-Up Of The PRIMA Study Confirms The Benefit Of 2-Year Rituximab Maintenance In Follicular Lymphoma Patients Responding To Frontline Immunochemotherapy

Gilles Andre Salles, MD, PhD, John Francis Seymour, MBBS, FRACP, PhD, Pierre Feugier, MD, PhD, Fritz Offner, MD, Armando Lopez-Guillermo, MD, PhD, David Belada, M.D., Ph.D., Luc Xerri, MD, PhD, Reda Bouabdallah, MD, John Catalano, MBBS FRACP FRCPA, Brice Pauline, MD, Dolores Caballero, MD, PhD, Corinne Haioun, MD, PhD, Lars Moller Pedersen, Alain Delmer, MD, David Simpson, Sirpa Leppa, Pierre Soubeyran, Anton Hagenbeek, MD, PhD, Olivier Casasnovas, MD, Tanin Intragumtornchai, MD, Christophe Ferme, MD, Maria Gomes da Silva, Catherine Sebban, MD, Andrew Lister, Jane A Estell, MBBS, FRCPA, FRACP, Gustavo Milone, Anne Sonet, MD, Bertrand Coiffier, MD, PhD, Herve Tilly, MD
Journal: Blood
Blood (2013) 122 (21): 509.
https://doi.org/10.1182/blood.V122.21.509.509
Published: 2013
Journal Articles

Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.

Gilles Andre Salles, MD, PhD, John Catalano, MBBS, FRACP, FRCPA, Pierre Feugier, MD, PhD, Fritz C Offner, MD, PhD, Reda Bouabdallah, MD, Dolores Caballero, MD, Pauline Brice, MD, Lars Moller Pedersen, MD, Corinne Haioun, MD, David Belada, MD, Alain Delmer, MD, David Simpson, FRACP, FRCPA, MB, CHB, Herve Tilly, MD, Sirpa Leppa, MD, Pierre Soubeyran, MD, Anton Hagenbeek, MD, PhD, Olivier Casasnovas, MD, Tanin Intragumtornchai, MD, MSc, Christophe Fermé, MD, Maria Gomes da Silva, MD, Catherine Sebban, MD, Andrew Lister, MD, Jane A Estell, MBBS, FRCPA, FRACP, Gustavo Milone, MD, Anne Sonet, MD, Armando Lopez-Guillermo, MD, John Francis Seymour, MBBS, FRACP, Ph, D, Luc Xerri, MD
Journal: Blood
Blood (2010) 116 (21): 1788.
https://doi.org/10.1182/blood.V116.21.1788.1788
Published: 2010
Journal Articles

Result of FDG PET-CT Imaging After Immunochemotherapy Induction Is a Powerful and Independent Prognostic Indicator of Outcome for Patients with Follicular Lymphoma: An Analysis From the PRIMA Study

Judith Trotman, MBChB, FRACP, FRCPA, Marion Fournier, Thierry Lamy, MD, PhD, Jane A Estell, MBBS, FRCPA, FRACP, Anne Sonet, MD, Andrea Janikova, MD, PhD, Herve Tilly, Didier Decaudin, Jean Gabarre, MD, John F Seymour, MD, FRACP, Etienne Garin, Cecily Forsyth, Michael Fulham, MBBS, FRACP, Thierry Vander Borght, MD, PhD, Ofer Shpilberg, MD, MPH, Gilles Salles
Journal: Blood
Blood (2010) 116 (21): 855.
https://doi.org/10.1182/blood.V116.21.855.855
Published: 2010